Keynote Speakers:

Executive Panelists:

Other Speakers:

Keynote Speakers:

Don Berwick, MD

Former Administrator, Centers for Medicare and Medicaid Services

Berwick is a leading advocate for high-quality health care and speaks about the challenges faced by modern health care systems. Prior to being the Administrator at the Centers for Medicare and Medicaid Services he was the founding CEO of the Institute for Healthcare Improvement, a nonprofit dedicated to improving health care around the world. Previously Berwick practiced as a pediatrician and served on the Harvard Medical School faculty.


Clayton M. Christensen

Author and Harvard Business School Professor

Christensen is regarded as one of the world's foremost experts on innovation and growth. His research has been applied to national economies, startup and Fortune 50 companies, as well as to early- and late-stage investing. Christensen is the best-selling, award-winning author of seven books, including The Innovator's Dilemma, which received the Global Business Book Award for the Best Business Book of the Year. Recently, Christensen has focused the lens of disruptive innovation on health care with The Innovator's Prescription, which examines how to fix our health care system.

He is a five-time recipient of the McKinsey Award for the Harvard Business Review's best article and the recipient of a Lifetime Achievement Award from the Tribeca Film Festival in 2010. Christensen is an experienced entrepreneur, having started three successful companies, and the founder of a nonprofit think tank whose mission is to apply his theories to vexing societal problems such as health care, education and clean energy.


Executive Panelists:

Graham Hughes, MD

Chief Medical Officer, SAS Center for Health Analytics and Insights

Hughes is responsible for identifying and developing opportunities to create novel analytics solutions that help health care organizations improve care quality, clinical operations and patient outcomes.

He has over 20 years' experience developing and delivering innovative health care IT products and services and is an expert on health care market dynamics, both in the United States and internationally. Prior to working at SAS, Hughes was the Vice President of Product Strategy and Chief Medical Informatics Officer at GE Healthcare IT. In that role he led a customer-facing advanced technologies innovation team and spearheaded the annual strategic planning process for GEHCIT's enterprise portfolio of products.


Steven Labkoff

Head of Strategic Programs, Research and Development Information, AstraZeneca

At AstraZeneca, Labkoff leads three teams that are dedicated to using health care data for the development of ethical pharmaceuticals. He focuses on strategies for new health care delivery models and has demonstrated success in the convergence of medicine, life sciences and policy across disparate organizations including government, non-government organizations (NGOs), health plans and academic institutions.

Previously, Labkoff was Medical Executive in the Medical Affairs group in Pfizer's Primary Care Business Unit. He founded and led the Healthcare Informatics Group (HCI). The HCI group worked in the external environment to seek out new opportunities from the growth of health information technology in America and around the world.

Labkoff is a former cardiologist and an internist. He received his medical training at University of Pittsburgh Medical Center and the University of Medicine and Dentistry of New Jersey.


Maureen O'Connor

Executive Vice President and Chief Strategy Officer, Blue Cross and Blue Shield of North Carolina

O'Connor leads the development and implementation of enterprise strategy, and is responsible for the health care and clinical division, network relationships and health system innovation, business development, analytics, health reform implementation, and public affairs. She joined BCBSNC in 2000 as Vice President and Deputy General Counsel and later assumed the roles of General Counsel and Chief Administrative Officer.

O'Connor has extensive experience in health policy and strategy, business development, provider relations and contracting and regulatory affairs. Before joining BCBSNC, O'Connor was Senior Regional Counsel with CIGNA, Senior Vice President and general counsel of Healthsource North Carolina and was in private practice with Smith, Anderson, Blount, Dorsett & Jernigan. While in private practice, O'Connor represented hospital systems, physician practices, state medical societies and boards, and other health-related organizations.

She serves on the national board of the Council for Affordable Quality Healthcare (CAQH) and co-chairs the finance committee of the North Carolina Health Information Exchange.


Other Speakers:

Dea Belazi

Vice President of Payer and Healthcare Solutions, Wolters Kluwer Health

Belazi's responsibilities include utilizing patients' medical/pharmacy claims data to conduct marketing, landscape assessments, and outcomes research for pharmaceuticals, devices and other health care services for US payers and pharmaceutical companies. Prior to this role, he was a consultant focused on pharmacy utilization management for health plans and PBMs. Belazi was actively engaged in PBMs and pharmaceutical companies in the area of managed care and payer marketing, pharmacy benefit management, health outcomes research and formulary strategies. Belazi is an adjunct faculty member at the University of Rhode Island College of Pharmacy and a Senior Fellow at Thomas Jefferson University, School of Population Health.

Francois de Brantes

Executive Director, HCI3

De Brantes is responsible for setting and implementing strategies, supervising implementations, leading the development of new programs and designing incentive efforts for employers, health plans and provider organizations.

Previously, de Brantes was the program leader for various health care initiatives at GE Corporate Health Care Programs and was responsible for developing the conceptual framework and the implementation of GE's Active Consumer strategy.

Lanier Cansler

President, Cansler Collaborative Resources Inc. and Former Secretary, North Carolina Department of Health and Human Services

Cansler has 20 years of experience as a certified public accountant with an emphasis on management services and the health care industry. He was elected to four terms in the North Carolina House of Representatives and served as co‐chair of the House Appropriations Subcommittee on Health and Human Services and co-chair of the Joint House/Senate Legislative Health Care Oversight Committee. In 2001, he was appointed Chief Deputy Secretary of the Department of Health and Human Services. In 2009, he was selected Secretary of Health and Human Services by Gov. Beverly Perdue. Cansler currently serves as the Chairman of the Board of the North Carolina Health Information Exchange Inc.

Christine Colombo

Senior Director, Informatics and Consultative Business Services, Independence Blue Cross

Colombo leads a team that consults with functional areas within Independence Blue Cross (IBC), as well as customers and providers, to improve performance using data and analytics. This includes program design and evaluation, risk stratification, marketing models, predictive modeling and analytics, and return on investment studies.

Colombo has held several leadership roles at IBC, including developing and executing a strategy to centralize analytics and technology in an Informatics organization. Prior to her role in Informatics, Colombo led the Research and Evaluation department at IBC, which focused on clinical analysis.

David Dimond

Chief Strategist of Health Sciences, EMC Global Solutions Group

Dimond is an expert on business and technology trends related to health sciences market convergence and the policies of reform. At EMC his team focuses on early-stage development of collaborative health care and big data solutions to meet international market demands. Before joining EMC, Dimond was a strategic advisor to several health care technology companies, startups and investment banks while co-founding the social media platform WhatNext.com.

Dimond has written numerous articles, technical papers and book chapters. He is an adjunct professor in the Babson College MBA program with a focus on the business of health care IT and also serves on the Strategic Advisory Council at Worcester Polytechnic Institute, where he guides the formation and growth of their Healthcare Delivery Institute.

Bernd Doetzkies

Director, Informatics, Daiichi Sankyo Pharma Development

Doetzkies is responsible for collaborating with clinical research functional areas to identify opportunities for process optimization through the innovative exploitation of information management technologies, and for ensuring that these systems are implemented and maintained in a regulatory-compliant manner.

Doetzkies has more than 29 years of experience developing and implementing research-based information management and analytical systems across a number of industries, including 20 years within the pharmaceutical industry. In addition to implementing systems, he has also led many business process improvement initiatives and standards implementation projects within clinical development.

Ted Doyle

Vice President, OptumInsight

Doyle has more than 27 years of health care insurance experience and has focused mostly on the detection and prevention of health care fraud and abuse.

Previously he worked with the US Federal Agency, the Centers for Medicare and Medicaid Services and with three large insurance companies/payers: Transamerica, WellPoint and UnitedHealth Group. He is nationally recognized in the US for expertise in creating and managing health care fraud solutions and is a two-time recipient of the US Health and Human Services Secretary's Award.

Doyle is a member of the Bureau of National Affairs Health Care Fraud Report Advisory Board, the AHIP national health care fraud workgroup, and the Association of Certified Fraud Examiners. He is an accredited Health Care Fraud Investigator through the National Health Care Anti-Fraud Association.

Bob Gabruk

North America Practice Leader, Enterprise Analytics Practice, Cognizant

Gabruk leads a global team of consulting and analytics professionals and has more than 20 years of experience in strategic consulting and quantitative analysis. Most recently, Gabruk focused on analyzing and influencing key buyers' decision-making processes to create a competitive advantage, particularly focusing on strategic marketing, promotional resource planning, selling effectiveness and business development. He also aligned human capital management to business strategy through organization design and process re-engineering. Prior to Cognizant, Gabruk worked at Deloitte Consulting in the life sciences practice and Titan Research and Technology in the statistical analysis and stochastic modeling group.

Scott Gee

Vice President, Finance and Chief Financial Officer, US UCB Inc.

Gee provides strategic support to the executive management team regarding key governmental requirements and new concepts in the financial industry. He is also responsible for the contracts management and purchasing organizations. Previously, he was responsible for redesigning the organizational structure of the customer contracts group, during which he instituted standard operating procedures and a compliance program for the contract process. Gee is a member of UCB's US Leadership Team and is a member of the board of directors for UCB Canada.

Patrick Genyn

Senior Director of Drug Development Sciences and Medical Development, Janssen Research and Development

Genyn has more than 25 years of experience in the pharmaceutical industry. He joined the Janssen Research Foundation in Beerse, Belgium, in 1987 and has held various positions and responsibilities in information technology and clinical development. Currently, he is leading an initiative for implementing and operating a master data governance and management capability across the drug development organizations. Genyn taught clinical data management as part of the quality assurance/regulatory affairs graduate program at Temple University.

Patrick Getzen

Chief Actuary, Blue Cross and Blue Shield of North Carolina

Getzen has 20 years of experience in the health insurance industry with emphasis on the areas of group and individual pricing, valuation, underwriting, product development and financial planning. His actuarial and underwriting experience included analysis of medical trends and establishing rates for group and individual products. He was also involved with provider compensation programs as well as evaluation of care management financial performance.

Getzen is a Fellow of the Society of Actuaries (FSA), Member of the American Academy of Actuaries (MAAA), and currently serves on the Board for Inclusive Health.

Shiraz Hasan

Practice Leader, Managed Markets Pharma Solutions, Wolters Kluwer Health

Hasan is a Practice Leader in Wolters Kluwer Health’s Pharma Solutions (WKPS) Group and has been an instrumental player in helping life science companies better compete with analytics. He is responsible for leading the practice around WKPS’ claims-based solutions, strategic partnerships and corporate development. For more than a decade he has focused his efforts on creating innovative approaches for the health care stakeholders to build franchise value. His previous experience includes general management, strategic planning, marketing  and sales management.

Derek Jones

Executive Director of Commercial Insight, AstraZeneca

Jones is responsible for leading all efforts to support the organization's insight, analytics and market research capabilities in the US. Most recently, he held the role of Senior Director of Managed Markets and Quantitative Decision Support. Prior to AstraZeneca, Jones was Senior Director of eBusiness Development at DuPont Pharmaceuticals, where he led the development of the company's e-business strategy for marketing and initiated several innovative programs within US and international operations. He also spent 11 years in the DuPont Medical Imaging business and has more than 20 years of experience in the pharmaceutical industry, including leadership roles in technology strategy, market research, managed markets, sales, product management and operations.

Stephen Kaczmarek

Consulting Actuary, Milliman

Kaczmarek has experience in consulting for pharmacy benefit managers (PBMs) and Medicare Part D prescription drug plan (PDP) sponsors. His work includes Part D bid development and filing, financial performance monitoring and projections and financial operations, including formulary analysis and decision making. Prior to joining Milliman, he worked at Cigna Healthcare and The Travelers Managed Care and Employee Benefits Organization. While at Cigna, he served as the business financial officer for the managed care book of business, which covered over 6 million members. Additionally, Kaczmarek was Cigna Healthcare's pharmacy pricing actuary and its first product development actuary.

Paula Kowalczyk

Senior Director, Merck Consumer Care IT

Kowalczyk is responsible for partnering with the business to define and build out processes and capabilities. Previously, she was Enterprise Architect in support of Merck's Global Support Functions. Prior to that, Kowalczyk supported Merck's Global Human Health division. Her responsibilities included the Multichannel Management initiative where several new capabilities were developed, including campaign management. She also led a program that defined a multi-year road map to move the organization to a more customer-centric model.

Sunny Longordo

Senior Analytics Leader

Longordo has more than 20 years of experience in life sciences analytics. Her most recent role was Senior Director of Sales Analytics with Johnson and Johnson, where she led teams of up to 65 professionals responsible for a variety of commercial analytics functions. Prior to that, Longordo held leadership positions in commercial analytics at Bristol-Myers Squibb and Knoll Pharmaceuticals. She also worked on the supplier side at Health Products Research, where she provided analytics consultation to pharmaceutical, biotech, diagnostics and consumer companies.

Don McDaniel

President and CEO, Sage Growth Partners

McDaniel is responsible for executing the firm's growth strategy and ensuring the delivery of high-value solutions to its clients. He is also a key advisor to a diverse group of high-profile clients in the health care industry and related industries. McDaniel is a member of the faculty in health economics and strategy in the Carey Business School's renowned Business of Health MBA program at The Johns Hopkins University.

McDaniel is a well-respected health economist and strategist and has held leadership roles at a number of health care, insurance and technology organizations. His expertise lies in the areas of strategic and business planning, innovation, applied economics, business development, product development, operations improvement, change management and the strategic deployment of information technology.

Michael Parkerson

Vice President of Marketing, Blue Cross and Blue Shield of North Carolina

Parkerson is responsible for moving Blue Cross and Blue Shield of North Carolina to be a more market-driven company and leads the enterprise growth strategy. Areas of responsibility include market strategy and planning, market offer management and oversight, product development, brand management, creative services and the Web office.

He currently serves on the boards of the Greater Raleigh Chamber of Commerce – Economic Development Plan and the North Carolina Opera.

Dan Renick

President, The Hobart Group

During his 20 years of experience in the health care industry, Renick has worked in several key areas, including managed care, pharmaceutical managed markets and pharmacy provider operations. Prior to joining The Hobart Group, Renick was Director of Corporate Pharmacy Management at Humana Inc. In this role, he was responsible for pharmacy programs and trade relations, including contracting oversight with both pharmaceutical companies and pharmacy provider organizations. Renick also spent several years in pharmacy operations at the regional and headquarters levels for both retail and long-term care pharmacy providers.

Frank W. Rockhold

Senior Vice President, Drug Development Sciences, Medicines Development, GlaxoSmithKline

Rockhold is responsible for case management, signal detection, safety evaluation, risk management for all development and marketed products. He is currently the co-chair of the GlaxoSmithKline Global Safety Board. Previously at GlaxoSmithKline, he held management positions within the Statistics and Epidemiology Department and Clinical Operations. Additionally, he was interim head of the Cardiovascular and Metabolic Medicines Development Center.

Rockhold is currently Chairman of the Board of Directors of the Clinical Data Interchange Standards Consortium (CDISC) and a member of the National Library of Medicine Advisory group for ClinicalTrials.gov. He is the former President of the Society for Clinical Trials, former Chair of the PhRMA Biostatistics Steering Committee, and a member of the ICH E-9 and E-10 Expert Working Groups.

Rockhold is a Fellow of the American Statistical Association and a Fellow of the Society for Clinical Trials. He is a recipient of the PhRMA Career Achievement award.

David Rubinow

Professor and Chief of Psychiatry and Chief Innovations Officer, University of North Carolina at Chapel Hill School of Medicine

Rubinow joined the University of North Carolina at Chapel Hill's School of Medicine in January 2005 as the Chair of Psychiatry and Professor of Medicine and was recently appointed as Director of Innovation and Health Care System Transformation for the UNC School of Medicine. Previously, Rubinow served as Clinical Director of the National Institute of Mental Health (NIMH) and the Chief of NIMH's Behavioral Endocrinology Branch. He received his MD from the University of Connecticut and completed an internship and residency at Yale University.

Kecia Serwin

Vice President and General Manager, SAS Health and Life Sciences

Serwin leads the comprehensive operations of three primary industry lines of business: health care providers, health plans and life sciences. She is a member of the SAS executive committee that is responsible for investing in new industry-specific solution offerings and go-to-market strategies for the health care and life sciences business unit. The committee's mission is to provide technology innovation that helps facilitate information sharing and analytical insights between the various members of the health care ecosystem with the goal of enabling health care transformation.

Anna Sickler

Research Analyst, Independence Blue Cross

Sickler is responsible for marketing analytics and has experience in data mining, predictive analytics and segmentation analytics. Since joining Independence Blue Cross, she has helped increase membership by building and implementing predictive models.

Ron Smith

Senior Vice President of Operations and Pharmacy Services, Physicians Pharmacy Alliance

Smith is responsible for the development of Physicians Pharmacy Alliance's (PPA) medication management service offerings to patient-centered medical homes, hospital health systems and key managed care clients. Prior to coming to PPA, Smith played a key role with Blue Cross and Blue Shield of North Carolina, where he was responsible for leading the company's strategic direction and health innovation efforts.

Smith currently serves on the Campbell University College of Health Sciences Board, and the advisory board for the Wake Forest University Center for Worker Health.

Peter Wickersham

Senior Vice President of Cost of Care, Prime Therapeutics

Wickersham leads efforts to promote the cost-effective use of prescription drugs for clients and delivery of innovative clinical programs that increase the health and well-being of its members. He focuses Prime Therapeutics' cost of care efforts beyond the traditional pharmacy to include how it links with ongoing client care management efforts in order to deliver a superior outcome for patients. Previously, he was Vice President of Operations at Cigna Pharmacy Management.

Brian Wolf, MD

Senior Medical Director, Blue Cross & Blue Shield of Rhode Island

Wolf's areas of expertise are clinical quality and health analytics. Since 2008 he has focused on the development of the local patient-centered medical home program. As a former surgical oncologist, he was Director of Surgical Services at the Whidden Memorial Hospital and Chief of General Surgery for the Cambridge Health Alliance, a Harvard teaching affiliate. Prior to this role, he was Chairman of the Physician Practice at Harvard Pilgrim Health Care.

Register Now